← Back
$TVTX All transactions

Travere Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

4,920

Price

$0

Filed

May 5

Insider

Name

ROTE WILLIAM E.

Title

Chief Research Officer

CIK

0001698262

Roles

Officer

Transaction Details

Transaction Date

2025-05-02

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,920

Footnotes

On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. | Each PSU represents a contingent right to receive one share of the common stock of the Issuer. | This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.

Filing Info

Accession No.

0001415889-25-012056

Form Type

4

Issuer CIK

0001438533

ROTE WILLIAM E.'s History

Date Ticker Type Value
2026-04-22 TVTX $356K
2026-04-13 TVTX A $0
2025-12-24 TVTX M $1.2M
2025-12-24 TVTX $2.4M
2025-12-24 TVTX M $0
2025-05-05 TVTX $67K
2025-05-02 TVTX M
2025-05-02 TVTX M $0

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.1M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$356K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$4.5M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$903K 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$43K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$349K 2026-04-15